Christiana Care scientists make colon cancer discovery - Technical.ly Delaware

Sciences

Oct. 16, 2018 7:33 am

Christiana Care scientists make colon cancer discovery

The Helen F. Graham Cancer & Research Institute’s findings may lead to new treatment options.
A potential new breakthrough for colon cancer has been discovered in Delaware.

A potential new breakthrough for colon cancer has been discovered in Delaware.

(Photo by Flickr user Michael (a.k.a. moik) McCullough, used under a Creative Commons license)

A recent study led by Bruce Boman of Christiana Care Health System, found that colon cancer stem cell activity may be inhibited by retinoic acid signaling. Retinoic acid, a vitamin A–derived molecule often found in topical anti-aging products (Retin-A), is used in cancer treatment due to its affect on cell development.

Colorectal cancer is the second leading cause of cancer-related deaths in the United States. It can be difficult to treat due to drug resistance; this discovery may help oncologists target these cancers with more success.

“Our findings point to a number of possibilities for developing more effective stem cell targeting therapies for advanced colorectal cancer,” Dr. Boman said.

The paper, published in the Oct. 5 issue of Oncotarget, is co-authored by former University of Delaware student researcher Shirin Modarai (who currently works for Christiana Care), among others.

Read the findings -30-
CONTRIBUTE TO THE
JOURNALISM FUND

Already a contributor? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

Sign-up for daily news updates from Technical.ly Delaware

Do NOT follow this link or you will be banned from the site!